Education Session
304 - Case Studies in Contained Active
Pharmaceutical Ingredients (API) Pilot and
Manufacturing Facilities
10 November 08.15-11.30
ISPE CEUs: 0.23
Tracks: FacilitiesProductionQuality
This is sponsored by the ISPE Active Pharmaceutical Ingredients (API) and Containment Communities of Practice (COPs)
This session will address contained API pilot and small scale manufacturing facilities. Through case studies, participants will learn about:
- Containment strategies
- Exposure risk from equipment (Is the closed process closed?)
- New build and retrofits
- Rigid vs. flexible
- Process innovations
How you will Benefit
At the end of this session, participants will be able to:
- Understand the latest trends in API system design
- Describe small scale API production systems (high value and potency) and therefore high hazard
- Explain the trend to small scale continuous process
- Discuss the issue of cost reduction and quality improvement
Who Should Attend
Engineers, process engineers, architects, and professionals in MEP, HVAC, operations, and API
ISPE Communities of Practice (COPs)
API, Containment, CU, Disposables, GCLP, HVAC, IP, OSD, PAT, PPD, PM, SPP, and SF
View the ISPE Community of Practice (COP) Guide
Session Leader
- Brian Rubin, Process Engineer, CRB Engineers USA
Session Presenters
- James Belval, Project Manager, CRB Consulting Engineers, Inc. USA
- Jonathan Lind, Distinguished Project Engineer, Roche Colorado Corp USA
- Richard McCabe, Senior Manager GMS, Pfizer USA
- Julian Wilkins, Vice President, PharmaConsult US Inc USA
